Latest News - The Aurum Institute

The Aurum Institute Announces New Group CEO to Lead Next Phase of Growth

JOHANNESBURG, 26 August 2024. The Aurum Institute, a leading Africa-based global health organisation today announced that Professor Dave Clark will succeed Professor Gavin Churchyard as Group CEO, e...
Building Sustainable Quality Improvement in Africa’s Healthcare

At the ACQUIRE QI Leadership Forum in Kenya, The Aurum Institute’s Regional Director, Ms Lauren De Kock, led key discussions on how African countries can integrate quality improvement (QI) into thei...
Leadership Transition at Aurum: Prof. Charalambous and Prof. Chihota

It is with great pleasure that we announce the leadership transitions of Prof. Violet Chihota and Prof. Salome Charalambous within Aurum, effective 1 August 2024. Prof. Chihota, now serving as Group ...
Aurum's Community Engagement Manager joins Global TB Advisory Board

The Aurum Institute is proud to announce that Blossom Makhubalo, our Community Engagement Manager, has been appointed as one of the newest members of the Global Tuberculosis Community Advisory Board (...
Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.

Jerome, R.N., Zahn, L.A., Abner, J.J., Joly, M.M., Shirey-Rice, J.K., Wallis, R.S., Bernard, G.R. and Pulley, J.M., 2024. Repurposing N-acetylcysteine for management of non-acetaminophen induced acute...
Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.

Maenetje P, Baik Y, Schramm DB, Vangu MDW, Wallis RS, Mlotshwa M, Tiemessen CT, Li Y, Kornfeld H, Churchyard G, Auld SC, Bisson GP. Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung F...
HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study

Lindquist, L., Kilembe, W., Karita, E., Price, M.A., Kamali, A., Kaleebu, P., Tang, J., Allen, S., Hunter, E., Gilmour, J. and Rowland-Jones, S.L., 2024, April. HLA-A* 23 Is Associated With Lower Odds...
Aurum Pharmacy Month Series Part 2: The Power of Collaboration

In celebration of Pharmacy Month, we turn the spotlight on two outstanding pharmacists from our Pretoria site—Liezl Nel and Henriette Bam— whose expertise and dedication is making a significant ...
Exploring the syndemic interaction between social, environmental and structural contexts of HIV infection in peri-mining areas in South Africa: a qualitative study

Chimoyi, L., Ndini, P., Oladimeji, M., Seatlholo, N., Mawokomatanda, K., Charalambous, S. and Setswe, G., 2024. Exploring the syndemic interaction between social, environmental and structural contexts...
Assessment of the performance of the plasma separation card for HIV-1 viral load monitoring in South Africa.

Chimoyi, L., Hans, L., Oladimeji, M., Kindra, G., Diallo, K., Ayalew, K., Setswe, G.K. and Carmona, S., 2024. Assessment of the performance of the plasma separation card for HIV-1 viral load monitorin...
Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

Fwambah, L., Andisi, C., Streatfield, C., Bromell, R., Hare, J., Esbjörnsson, J., Ndung’u, T., Sanders, E.J., Hassan, A.S. and Nduati, E., 2024. Exposure to common infections may shape basal immuni...
. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Moodie, Z., Andersen-Nissen, E., Grunenberg, N., Dintwe, O.B., Omar, F.L., Kee, J.J., Bekker, L.G., Laher, F., Naicker, N., Jani, I. and Mgodi, N.M., 2024. Safety and immunogenicity of a subtype C ALV...
Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeconomic Conditions.

Wand, H., Naidoo, S., Govender, V., Reddy, T. and Moodley, J., 2024. Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeco...
Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.

Jerome, R.N., Zahn, L.A., Abner, J.J., Joly, M.M., Shirey-Rice, J.K., Wallis, R.S., Bernard, G.R. and Pulley, J.M., 2024. Repurposing N-acetylcysteine for management of non-acetaminophen induced acute...
Prevalence and factors associated with self-reported HIV testing among adolescent girls and young women in Rwanda: evidence from 2019/20 Rwanda Demographic and Health Survey.

Musekiwa, A., Silinda, P., Bamogo, A., Twabi, H.S., Mohammed, M., Batidzirai, J.M., Matsena Zingoni, Z., Singini, G.C., Moyo, M., Mchunu, N.N. and Ekwomadu, T.I., 2022. Prevalence and factors associat...
Reply to McShane.

Hill, P.C., Cobelens, F., Martinez, L., Garcia-Basteiro, A.L., Behr, M.A., Rangaka, M.X., Churchyard, G., Evans, T., Hanekom, W. and White, R.G., 2024. Reply to McShane. The Journal of Infectious Dis...
Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants – A multicountry study.

Tadesse, A.W., Mganga, A., Dube, T.N., Alacapa, J., van Kalmthout, K., Letta, T., Mleoh, L., Garfin, A.M., Maraba, N., Charalambous, S. and Foster, N., 2024. Feasibility and acceptability of the smart...
Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomised controlled trial.

Mabuto, T., Woznica, D.M., Ndini, P., Moyo, D., Abraham, M., Hanrahan, C., Charalambous, S., Zack, B., Baral, S., Owczarzak, J. and Hoffmann, C.J., 2024. Transitional community adherence support for p...
. Impact of coronavirus disease 2019-related clinic closures on HIV incidence in young adult MSM and transgender women in Kenya.

Wahome, E., Otieno, F.O., Kimani, J., Boyd, A., Okall, D., Nzioka, J., Gichuru, E., van der Elst, E., Mehta, S.D., Bailey, R.C. and Graham, S.M., 2022. Impact of COVID-19-related clinic closures on HI...
What is next for BCG revaccination to prevent tuberculosis?

White, R.G., Fiore-Gartland, A.J., Hanekom, W.A., Vekemans, J., Garcia-Basteiro, A.L., Churchyard, G., Rangaka, M.X., Frick, M., Behr, M.A., Hill, P.C. and Mave, V., 2024. What is next for BCG revacci...

The Aurum Institute Announces New Group CEO to Lead Next Phase of Growth

Building Sustainable Quality Improvement in Africa’s Healthcare

Leadership Transition at Aurum: Prof. Charalambous and Prof. Chihota

Aurum's Community Engagement Manager joins Global TB Advisory Board

Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.

Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.

HLA-A*23 Is Associated With Lower Odds of Acute Retroviral Syndrome in Human Immunodeficiency Virus Type 1 Infection: A Multicenter Sub-Saharan African Study

Aurum Pharmacy Month Series Part 2: The Power of Collaboration

Exploring the syndemic interaction between social, environmental and structural contexts of HIV infection in peri-mining areas in South Africa: a qualitative study

Assessment of the performance of the plasma separation card for HIV-1 viral load monitoring in South Africa.

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.

. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.

Preventing Stunting in South African Children Under 5: Evaluating the Combined Impacts of Maternal Characteristics and Low Socioeconomic Conditions.

Repurposing N-acetylcysteine for management of non-acetaminophen induced acute liver failure: an evidence scan from a global health perspective.

Prevalence and factors associated with self-reported HIV testing among adolescent girls and young women in Rwanda: evidence from 2019/20 Rwanda Demographic and Health Survey.

Reply to McShane.

Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among ASCENT trial participants – A multicountry study.

Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomised controlled trial.

. Impact of coronavirus disease 2019-related clinic closures on HIV incidence in young adult MSM and transgender women in Kenya.

What is next for BCG revaccination to prevent tuberculosis?

Popular Tags

Most Read

Recent Posts